92 related articles for article (PubMed ID: 11529562)
1. Immunomodulatory effect of gold sodium thiomalate on murine acquired immunodeficiency syndrome.
Yamaguchi K; Ushijima H; Hisano M; Inoue Y; Shimamura T; Hirano T; Müller WE
Microbiol Immunol; 2001; 45(7):549-55. PubMed ID: 11529562
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Curcuma longa L., Purple Sweet Potato, and Mixtures of the Two on Immunomodulation in C57BL/6J Mice Infected with LP-BM5 Murine Leukemia Retrovirus.
Park SJ; Lee D; Lee M; Kwon HO; Kim H; Park J; Jeon W; Cha M; Jun S; Park K; Lee J
J Med Food; 2018 Jul; 21(7):689-700. PubMed ID: 29862890
[TBL] [Abstract][Full Text] [Related]
3. Accelerated progression of a murine retrovirus-induced immunodeficiency syndrome in Fas mutant C57BL/6 lpr/lpr mice.
Hiromatsu K; Usami J; Aoki Y; Makino M; Yoshikai Y
Microbiol Immunol; 1997; 41(3):221-7. PubMed ID: 9130234
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory and Antioxidant Effects of Purple Sweet Potato Extract in LP-BM5 Murine Leukemia Virus-Induced Murine Acquired Immune Deficiency Syndrome.
Kim OK; Nam DE; Yoon HG; Baek SJ; Jun W; Lee J
J Med Food; 2015 Aug; 18(8):882-9. PubMed ID: 26076116
[TBL] [Abstract][Full Text] [Related]
5. Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice.
Sasaki H; Kobayashi M; Pollard RB; Suzuki F
Pathobiology; 2001; 69(2):96-103. PubMed ID: 11752903
[TBL] [Abstract][Full Text] [Related]
6. Effects of LP-BM5 murine leukemia virus infection on errors and response time in a two-choice serial reaction time task in C57BL/6 mice.
Lee B; Tumu P; Paul IA
Brain Res; 2002 Sep; 948(1-2):1-7. PubMed ID: 12383949
[TBL] [Abstract][Full Text] [Related]
7. Resistance to murine AIDS in offspring of mice infected with LP-BM5. Role of CD8 T cells.
Pavlovitch JH; Hulier E; Rizk-Rabin M; Marussig M; Mazier D; Joffret ML; Hoos S; Papiernik M
J Immunol; 1996 Jun; 156(12):4757-63. PubMed ID: 8648122
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of cyclosporin A on immune abnormalities observed in the murine acquired immunodeficiency syndrome.
Cerny A; Merino R; Makino M; Waldvogel FA; Morse HC; Izui S
Eur J Immunol; 1991 Jul; 21(7):1747-50. PubMed ID: 1647958
[TBL] [Abstract][Full Text] [Related]
9. Timed ablation of regulatory CD4+ T cells can prevent murine AIDS progression.
Beilharz MW; Sammels LM; Paun A; Shaw K; van Eeden P; Watson MW; Ashdown ML
J Immunol; 2004 Apr; 172(8):4917-25. PubMed ID: 15067071
[TBL] [Abstract][Full Text] [Related]
10. Quinolinic acid levels in a murine retrovirus-induced immunodeficiency syndrome.
Sei Y; Paul IA; Saito K; Layar R; Hartley JW; Morse HC; Skolnick P; Heyes MP
J Neurochem; 1996 Jan; 66(1):296-302. PubMed ID: 8522967
[TBL] [Abstract][Full Text] [Related]
11. ZDV delays but does not prevent the transmission of MAIDS by LP-BM5 MuLV-infected macrophage-monocytes.
Bilello JA; Kort JJ; MacAuley C; Fredrickson TN; Yetter RA; Eiseman JL
J Acquir Immune Defic Syndr (1988); 1992; 5(6):571-6. PubMed ID: 1316959
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS.
Green KA; Noelle RJ; Green WR
Virology; 1998 Feb; 241(2):260-8. PubMed ID: 9499800
[TBL] [Abstract][Full Text] [Related]
13. Suppressed mucosal lymphocyte populations by LP-BM5 murine leukemia virus infection producing murine AIDS.
Lopez MC; Colombo LL; Huang DS; Watson RR
Reg Immunol; 1992; 4(3):162-7. PubMed ID: 1338892
[TBL] [Abstract][Full Text] [Related]
14. Effect of selenium supplementation on mice infected with LP-BM5 MuLV, a murine AIDS model.
Chen C; Zhou J; Xu H; Jiang Y; Zhu G
Biol Trace Elem Res; 1997; 59(1-3):187-93. PubMed ID: 9522061
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of cytokine genes in peritoneal macrophages from mice infected with LP-BM5 MuLV, a murine model of AIDS.
Cheung SC; Chattopadhyay SK; Hartley JW; Morse HC; Pitha PM
J Immunol; 1991 Jan; 146(1):121-7. PubMed ID: 1701789
[TBL] [Abstract][Full Text] [Related]
16. Modulation of specific T cell responses by concurrent infection with Leishmania major and LP-BM5 murine leukemia viruses.
Doherty TM; Morse HC; Coffman RL
Int Immunol; 1995 Jan; 7(1):131-8. PubMed ID: 7718509
[TBL] [Abstract][Full Text] [Related]
17. Impaired IL-15 production associated with susceptibility of murine AIDS to mycobacterial infection.
Umemura M; Hirose K; Wajjwaiku W; Nishimura H; Matsuguchi T; Gotoh Y; Takahashi M; Makino M; Yoshikai Y
J Leukoc Biol; 2001 Jan; 69(1):138-48. PubMed ID: 11200058
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of interleukin-15 prevents the development of murine retrovirus-induced acquired immunodeficiency syndrome.
Umemura M; Nishimura H; Yajima T; Wajjwalk W; Matsuguchi T; Takahashi M; Nishiyama Y; Makino M; Nagai Y; Yoshikai Y
FASEB J; 2002 Nov; 16(13):1755-63. PubMed ID: 12409318
[TBL] [Abstract][Full Text] [Related]
19. Antiviral efficacy and toxicity of ribavirin in murine acquired immunodeficiency syndrome model.
Harvie P; Omar RF; Dusserre N; Désormeaux A; Gourde P; Tremblay M; Beauchamp D; Bergeron MG
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):451-61. PubMed ID: 8757421
[TBL] [Abstract][Full Text] [Related]
20. Cryptococcus neoformans infection in mice previously infected with LP-BM5 MuLV, the agent of murine AIDS (MAIDS).
Lacroix C; Chau F; Carbon C; Sinet M; Derouin F
Clin Exp Immunol; 1997 Nov; 110(2):196-202. PubMed ID: 9367402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
